切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Adenosine A2A Receptors - Calcium-Activated Potassium (KCa) Channels - Menin-MLL - S1P receptors

13件产品中的 1-10

页面
每页
清除全部
  1. Regadenoson
    B5904 Regadenoson
     1 Citation
    中文名: 类伽腺苷
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体激动剂
      ≥18.05 mg/mL
      insoluble in H2O
  2. RP 001 hydrochloride
    B7634 RP 001 hydrochloride
    Target: S1P receptors
    Summary: S1P1受体激动剂
      <43.25 mg/mL
  3. SCH 58261
    B6995 SCH 58261
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体竞争性拮抗剂
      ≥34.5 mg/mL
      insoluble in H2O
  4. Dequalinium Chloride
    B2191 Dequalinium Chloride
    中文名: 地喹氯铵
    Target: PKC|Calcium-Activated Potassium (KCa) Channels
    Summary: PKC抑制剂
      insoluble in DMSO
      insoluble in H2O
  5. BAF312 (Siponimod)
    B3225 BAF312 (Siponimod)
     1 Citation
    中文名: 辛波莫德
    Target: S1P receptors
    Summary: S1P受体激动剂
      ≥194.8 mg/mL
      insoluble in H2O
  6. Fingolimod (FTY720)
    A8548 Fingolimod (FTY720)
    中文名: 盐酸芬戈莫德
    Target: S1P receptors
    Summary: S1P受体激动剂
      ≥17.2 mg/mL
      ≥31.3 mg/mL
  7. Istradefylline (KW-6002)
    A8454 Istradefylline (KW-6002)
    中文名: 伊曲茶碱
    Target: Adenosine A2A Receptors
    Summary: 选择性A2A受体拮抗剂
      ≥8.78 mg/mL
      insoluble in H2O
  8. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  9. TRAM-34
    A1888 TRAM-34
    Target: Calcium-Activated Potassium (KCa) Channels
    Summary: KCa3.1阻断剂
      ≥17.25 mg/mL
      insoluble in H2O
  10. Tozadenant
    A3885 Tozadenant
    Target: Adenosine A2A Receptors
    Summary: 腺苷2A受体拮抗剂
      ≥20.35 mg/mL
      insoluble in H2O

13件产品中的 1-10

页面
每页